What is the current Antiparasitic Drugs for Pets market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Antiparasitic Drugs for Pets market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Antiparasitic Drugs for Pets market?

Increasing pet ownership and rising awareness of parasitic diseases drive the market.

What challenges does the Antiparasitic Drugs for Pets market face?

Resistance to antiparasitic drugs and stringent regulatory frameworks pose challenges.

Which regions lead the Antiparasitic Drugs for Pets market?

North America and Europe are the leading regions due to high pet ownership.

Who are the top companies in the Antiparasitic Drugs for Pets market?

Top companies include Zoetis, Merck, and Bayer, offering a range of antiparasitic products.

What future opportunities exist in the Antiparasitic Drugs for Pets market?

Growing demand for natural and organic products presents opportunities for innovation.

How does technology impact the Antiparasitic Drugs for Pets market?

Advances in diagnostic technologies improve treatment outcomes and drive market growth.

What is the regulatory landscape for the Antiparasitic Drugs for Pets market?

Regulatory frameworks vary by region, with stringent regulations in developed markets.

What is the future outlook for the Antiparasitic Drugs for Pets market?

The market is expected to experience steady growth, driven by increasing pet humanization.

Antiparasitic Drugs for Pets Market: Opportunity by 2034 | In-Depth Report

Antiparasitic Drugs for Pets by Application (Cats, Doges, Others), by Types (In Vitro Deworming Medicine, In Vivo Deworming Medicine), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $4.2 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $4.2 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Antiparasitic Drugs for Pets Market Overview

The Antiparasitic Drugs for Pets market is a vital segment of the animal healthcare industry, focusing on the development and distribution of medications that prevent and treat parasitic infections in pets. As the global pet population continues to grow, the Antiparasitic Drugs for Pets market size is estimated to be around $1.4 billion, with a growth outlook that is expected to be driven by increasing awareness about pet health and the importance of parasite control. The market forecast suggests a compound annual growth rate (CAGR) of 7.3% from 2026 to 2033, with key drivers including advancements in pharmaceutical technology, stringent regulations, and shifting consumer behavior towards premium pet care products. The industry expansion is expected to be shaped by factors such as the rise of e-commerce, increasing competition, and the growing demand for natural and organic pet care products.

Loading chart…

The largest region in the Antiparasitic Drugs for Pets market is North America, accounting for over 40% of the global market share, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing pet ownership and rising awareness about pet health. Key forces shaping the industry include technology shifts, such as the development of new formulations and delivery systems, regulations, such as stricter guidelines for product safety and efficacy, and consumer behavior, such as the growing demand for natural and organic products. As the market continues to evolve, manufacturers will need to adapt to changing consumer preferences, technological advancements, and regulatory requirements to remain competitive and drive market growth.

Report Overview

Report Attribute	Details
Market size value in 2025	4.20 million
Revenue forecast in 2033	7.66 million
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Zoetis; Boehringer Ingelheim; Merck; Elanco; Virbac; Ceva; Vetoquinol; Ouro Fino Saude; JINDUN; Zhongbolvya; CAHIC
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Antiparasitic Drugs for Pets market is poised for significant growth, driven by increasing pet ownership and the rising prevalence of parasitic infections among pets. Understanding the market dynamics is crucial for stakeholders to navigate this complex landscape.

Growth Drivers2 items

The expansion of the pet care industry, fueled by increasing humanization of pets and a growing awareness of animal health, is driving the demand for Antiparasitic Drugs for Pets, thereby contributing to the growth forecast of the Antiparasitic Drugs for Pets market size.

Advances in veterinary medicine and the development of novel, more effective Antiparasitic Drugs for Pets are further propelling the market, with a significant impact on the overall growth forecast.

Restraints2 items

The high cost of certain Antiparasitic Drugs for Pets, particularly those recently developed, can limit their adoption among pet owners, potentially constraining the growth of the Antiparasitic Drugs for Pets market size.

Stringent regulatory requirements for the approval of new Antiparasitic Drugs for Pets can slow down the entry of new products into the market, affecting the overall growth forecast of the Antiparasitic Drugs for Pets market.

Opportunities2 items

The increasing awareness of the importance of preventive care in pets presents an opportunity for the Antiparasitic Drugs for Pets market to grow, as pet owners seek to protect their pets from parasitic infections, thus influencing the Antiparasitic Drugs for Pets market size.

The development of generic versions of Antiparasitic Drugs for Pets can expand the customer base by offering more affordable options, contributing to the growth forecast of the market.

Challenges2 items

The emergence of resistance to existing Antiparasitic Drugs for Pets poses a significant challenge, requiring continuous research and development of new, effective treatments to maintain the growth forecast of the Antiparasitic Drugs for Pets market.

Ensuring the sustainability of the supply chain for Antiparasitic Drugs for Pets, especially in the face of global health crises, is crucial for the uninterrupted growth of the Antiparasitic Drugs for Pets market size.

Market Segmentation

Loading chart…

The Application segment of the Antiparasitic Drugs for Pets market refers to the various uses of these drugs in treating parasitic infections in pets. This segment is crucial in understanding the Antiparasitic Drugs for Pets segmentation, as it helps in identifying the specific areas where these drugs are most effective. The application segment includes subtypes such as flea and tick control, heartworm prevention, and intestinal parasite control. Each of these subtypes contributes to the overall market size, with flea and tick control being the largest contributor.

The Types segment of the Antiparasitic Drugs for Pets market categorizes these drugs based on their active ingredients and modes of action. This segment is vital in market taxonomy, as it enables the classification of drugs into distinct categories. The types segment includes subtypes such as ectoparasiticides, endoparasiticides, and endectocides. Ectoparasiticides are the largest segment, accounting for a significant share of the market. Understanding the types segment is essential for analyzing the Antiparasitic Drugs for Pets market, as it helps in identifying the most effective drugs for specific parasitic infections.

Antiparasitic Drugs for Pets Segmentation Breakdown7 items

Application

Cats

Doges

Others

Types

In Vitro Deworming Medicine

In Vivo Deworming Medicine

Regional Insights

Loading chart…

The Antiparasitic Drugs for Pets market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 35% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing pet ownership and rising awareness about pet health.

Key drivers for North America include strong adoption of antiparasitic drugs, favorable policies supporting pet health, and significant investments in research and development. In Europe, drivers include high ecosystem maturity, growing demand for pet care services, and increasing awareness about zoonotic diseases. Asia Pacific is driven by rapidly growing pet populations, expanding distribution networks, and government initiatives promoting pet health.

In Latin America, key drivers include growing middle-class populations, increasing pet humanization, and improving infrastructure for pet care services. The Middle East & Africa region is driven by rising pet ownership, growing awareness about pet health, and investments in veterinary care infrastructure. These regional drivers are expected to contribute to the overall regional forecast for the Antiparasitic Drugs for Pets market.

Competitive Landscape

The Antiparasitic Drugs for Pets market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. The Antiparasitic Drugs for Pets competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players tend to focus on premium pricing and strong distribution networks, while local companies often prioritize regional expansion and cost advantages.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Common differentiation factors include technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are adapting their strategies to address these challenges and maintain competitiveness.

Zoetis: regional expansion

Boehringer Ingelheim: innovation pipeline

Merck: premium pricing

Elanco: vertical integration

Virbac: local manufacturing

Ceva: OEM tie-ups

Key Antiparasitic Drugs for Pets Companies11 items

Zoetis

Boehringer Ingelheim

Merck

Elanco

Virbac

Ceva

Vetoquinol

Ouro Fino Saude

JINDUN

Zhongbolvya

CAHIC

Market Ecosystem

The Antiparasitic Drugs for Pets ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured as raw materials and components are sourced from suppliers, manufactured into antiparasitic drugs by OEMs, and then distributed to end users through various channels. A thorough value chain analysis is essential to understand the intricacies of this ecosystem.

Raw material suppliers — providing active pharmaceutical ingredients

OEMs/manufacturers — producing antiparasitic drugs

Distributors/channel partners — delivering products to veterinarians and pet owners

Service providers/after-sales — offering support and guidance on product usage

End users/buyers — veterinarians, pet owners, and animal shelters

Regulators/standards bodies — overseeing product safety and efficacy

Data/analytics providers — tracking sales, disease prevalence, and treatment outcomes

In the Antiparasitic Drugs for Pets ecosystem, control points are primarily held by regulators and end users, as they influence adoption and drive demand. Dependency risks arise from input constraints, such as sourcing of raw materials, and standards approvals, which can impact product availability. Switching costs and partnerships also play a crucial role, as manufacturers may need to adapt to changing regulations or form alliances with distributors to expand their reach. The ecosystem's dynamics can vary by region, with different areas having distinct disease prevalence patterns, regulatory frameworks, and market preferences.

Recent Industry Insights

The Antiparasitic Drugs for Pets industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between major pharmaceutical companies have led to the creation of innovative products, expanding the market's portfolio. Notable mergers and acquisitions have also taken place, resulting in increased market consolidation and competition. Furthermore, several product launches have been observed, focusing on improved efficacy and safety for pets. Regulatory changes have been implemented to ensure the responsible use of antiparasitic drugs, and there has been a shift in consumer trends towards more natural and sustainable pet care products.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Antiparasitic Drugs for Pets market outlook. The market attractiveness is moderate, driven by increasing pet ownership and rising awareness about parasite control. Competitive intensity is high, with several key players competing for market share. The long-term outlook is positive, with the market expected to grow due to advancements in _innovation_ and increasing demand for effective antiparasitic treatments.

The innovation landscape is evolving, with a focus on developing safer and more effective treatments. Demand-supply balance is expected to be stable, with key players investing in research and development to meet growing demand. However, key risk factors include regulatory challenges and increasing competition from generic products, which may impact market growth. Overall, the Antiparasitic Drugs for Pets market outlook is promising, with opportunities for growth and innovation in the coming years.

12 items

1. Executive Summary

2. Antiparasitic Drugs for Pets Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Antiparasitic Drugs for Pets Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Antiparasitic Drugs for Pets Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Antiparasitic Drugs for Pets Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Antiparasitic Drugs for Pets Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Antiparasitic Drugs for Pets Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Antiparasitic Drugs for Pets Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Antiparasitic Drugs for Pets Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Antiparasitic Drugs for Pets Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Antiparasitic Drugs for Pets Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Antiparasitic Drugs for Pets Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Antiparasitic Drugs for Pets Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Antiparasitic Drugs for Pets Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Antiparasitic Drugs for Pets Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Antiparasitic Drugs for Pets Market Competition by Key Manufacturers

9.1. Global Antiparasitic Drugs for Pets Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Antiparasitic Drugs for Pets: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Zoetis

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Boehringer Ingelheim

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Merck

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Elanco

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Virbac

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Ceva

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Vetoquinol

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Ouro Fino Saude

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. JINDUN

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Zhongbolvya

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. CAHIC

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Antiparasitic Drugs for Pets Market

Figure 4: Global Antiparasitic Drugs for Pets Market: Drivers

Figure 5: Global Antiparasitic Drugs for Pets Market: Challenges

Figure 6: Global Antiparasitic Drugs for Pets Market: Trends

Figure 7: Global Antiparasitic Drugs for Pets Market: Opportunity

Figure 8: Global Antiparasitic Drugs for Pets Market: Restraint

Figure 9: Global Antiparasitic Drugs for Pets Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Antiparasitic Drugs for Pets Market Value (USD Million) By Region

Figure 19: Global Antiparasitic Drugs for Pets Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Antiparasitic Drugs for Pets Market Value (USD Million) By Region

Figure 27: Global Antiparasitic Drugs for Pets Market Share (%) By: Regions (2032)

Figure 28: Global Antiparasitic Drugs for Pets Market Volume (K) By Region

Figure 29: Global Antiparasitic Drugs for Pets Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Antiparasitic Drugs for Pets Market Value (USD Million) By Region

Figure 37: Global Antiparasitic Drugs for Pets Market Share (%) By: Regions (2032)

Figure 38: Global Antiparasitic Drugs for Pets Market Volume (K) By Region

Figure 39: Global Antiparasitic Drugs for Pets Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

117 items

Table 1: Market Segmentation Analysis

Table 2: Global Antiparasitic Drugs for Pets Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Antiparasitic Drugs for Pets Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Antiparasitic Drugs for Pets Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Antiparasitic Drugs for Pets Market Value (USD Million) By Region

Table 14: Global Antiparasitic Drugs for Pets Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Antiparasitic Drugs for Pets Market Volume (K) By Region

Table 31: Global Antiparasitic Drugs for Pets Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Antiparasitic Drugs for Pets Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Antiparasitic Drugs for Pets Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Antiparasitic Drugs for Pets Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Zoetis Basic Information And Sales Area

Table 52: Zoetis. Products Portfolio

Table 53: Boehringer Ingelheim Basic Information And Sales Area

Table 54: Boehringer Ingelheim. Products Portfolio

Table 55: Merck Basic Information And Sales Area

Table 56: Merck. Products Portfolio

Table 57: Elanco Basic Information And Sales Area

Table 58: Elanco. Products Portfolio

Table 59: Virbac Basic Information And Sales Area

Table 60: Virbac. Products Portfolio

Table 61: Ceva Basic Information And Sales Area

Table 62: Ceva. Products Portfolio

Table 63: Vetoquinol Basic Information And Sales Area

Table 64: Vetoquinol. Products Portfolio

Table 65: Ouro Fino Saude Basic Information And Sales Area

Table 66: Ouro Fino Saude. Products Portfolio

Table 67: JINDUN Basic Information And Sales Area

Table 68: JINDUN. Products Portfolio

Table 69: Zhongbolvya Basic Information And Sales Area

Table 70: Zhongbolvya. Products Portfolio

Table 71: CAHIC Basic Information And Sales Area

Table 72: CAHIC. Products Portfolio

Table 73: Global Market Value (USD Million) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Value (USD Million) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global Market Volume (K) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Volume (K) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Antiparasitic Drugs for Pets Market Value (USD Million) By Region

Table 82: Global Antiparasitic Drugs for Pets Market Share (%) By Region (2025-2032)

Table 83: North America Market Value (USD Million) (2025-2032) By Country

Table 84: North America Market Value (USD Million) (2025-2032) By Application

Table 85: North America Market Value (USD Million) (2025-2032) By Types

Table 86: Europe Market Value (USD Million) (2025-2032) By Country

Table 87: Europe Market Value (USD Million) (2025-2032) By Application

Table 88: Europe Market Value (USD Million) (2025-2032) By Types

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 90: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 92: South America Market Value (USD Million) (2025-2032) By Country

Table 93: South America Market Value (USD Million) (2025-2032) By Application

Table 94: South America Market Value (USD Million) (2025-2032) By Types

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 96: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 98: Global Antiparasitic Drugs for Pets Market Volume (K) By Region

Table 99: Global Antiparasitic Drugs for Pets Market Share (%) By Region (2025-2032)

Table 100: North America Market Volume (K) (2025-2032) By Country

Table 101: North America Market Volume (K) (2025-2032) By Application

Table 102: North America Market Volume (K) (2025-2032) By Types

Table 103: Europe Market Volume (K) (2025-2032) By Country

Table 104: Europe Market Volume (K) (2025-2032) By Application

Table 105: Europe Market Volume (K) (2025-2032) By Types

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 107: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 109: South America Market Volume (K) (2025-2032) By Country

Table 110: South America Market Volume (K) (2025-2032) By Application

Table 111: South America Market Volume (K) (2025-2032) By Types

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 113: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 115: Research Programs/Design For This Report

Table 116: Key Data Information From Secondary Sources

Table 117: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Antiparasitic Drugs for Pets Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	4.20 million
Revenue forecast in 2033	7.66 million
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Zoetis; Boehringer Ingelheim; Merck; Elanco; Virbac; Ceva; Vetoquinol; Ouro Fino Saude; JINDUN; Zhongbolvya; CAHIC
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advances in veterinary medicine and the development of novel, more effective Antiparasitic Drugs for Pets are further propelling the market, with a significant impact on the overall growth forecast.

Restraints2 items

Opportunities2 items

The development of generic versions of Antiparasitic Drugs for Pets can expand the customer base by offering more affordable options, contributing to the growth forecast of the market.

Challenges2 items

Market Segmentation

Loading chart…

Antiparasitic Drugs for Pets Segmentation Breakdown7 items

Application

Cats

Doges

Others

Types

In Vitro Deworming Medicine

In Vivo Deworming Medicine

Regional Insights

Loading chart…

Competitive Landscape

Zoetis: regional expansion

Boehringer Ingelheim: innovation pipeline

Merck: premium pricing

Elanco: vertical integration

Virbac: local manufacturing

Ceva: OEM tie-ups

Key Antiparasitic Drugs for Pets Companies11 items

Zoetis

Boehringer Ingelheim

Merck

Elanco

Virbac

Ceva

Vetoquinol

Ouro Fino Saude

JINDUN

Zhongbolvya

CAHIC

Market Ecosystem

Raw material suppliers — providing active pharmaceutical ingredients

OEMs/manufacturers — producing antiparasitic drugs

Distributors/channel partners — delivering products to veterinarians and pet owners

Service providers/after-sales — offering support and guidance on product usage

End users/buyers — veterinarians, pet owners, and animal shelters

Regulators/standards bodies — overseeing product safety and efficacy

Data/analytics providers — tracking sales, disease prevalence, and treatment outcomes

Recent Industry Insights

Analyst Overview

Table of Contents